Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?
DOI:
https://doi.org/10.47338/jns.v8.242Keywords:
Congenital mesoblastic nephroma, Recurrence, Adjuvant therapy, NeonateAbstract
Congenital mesoblastic nephroma (CMN) is a rare renal tumor of infancy. Complete surgical excision is often sufficient. A premature neonate underwent left radical nephrectomy for CMN without any adjuvant therapy. Pathology was consistent with cellular type CMN. Six months postoperatively, the patient developed recurrence. He subsequently underwent re-excision without any adjuvant chemotherapy. The baby is tumor free for more than a year.Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Downloads
Published
2019-12-27
How to Cite
1.
Nahla K, Dorsaf M, Samia B, Nahla H, Rachida L, Mongi M, Mohssen B, Abdellatif N. Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?. J Neonatal Surg [Internet]. 2019Dec.27 [cited 2024Mar.19];8(3):22. Available from: https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/242
Issue
Section
Case Report
License
Copyright (c) 2019 kechiche nahla
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.